Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This week, NDS is hosting the International Pancreas and Islet Transplantation Association (IPITA) 16th International Congress in Oxford. This is the first time that this biennial meeting has been held in the UK.

The meeting brings together the leading scientists and clinicians from across the world in the field of transplantation for type 1 diabetes (both solid organ pancreas transplantation and islet cell transplantation). State-of-the-art advances are being discussed, including stem cell transplantation and implantable devices that could end the end for anti-rejection medication with islet cell transplants.

Professor Paul Johnson, the Chair of the Local Organising Committee (IPITA 2017), said: ‘It is a great privilege to have been entrusted with hosting the IPITA 2017 Congress in Oxford. The UK has a strong track record in the fields of whole pancreas and islet transplantation and has been instrumental in a number of key developments including being one of the first countries in the world to have a nationally commissioned clinical islet transplant programme, as well as establishing the first joint whole organ and islet donor pancreas allocation scheme.’

The Congress is being held at the Mathematics Institute in Oxford with over 400 delegates and is a partnership between NDS and IPITA.

More information can be found at: http://www.ipita2017.org/ and https://twitter.com/ipita2017

The International Pancreas and Islet Transplantation Association (IPITA) 16th International Congress in Oxford.© NDS

Similar stories

New Cochrane evidence explores treatment options for chronic ear disease

Publication Research

A new Evidently Cochrane blog post for World Hearing Day summarises seven recent reviews on medical treatments for infection and inflammation of the middle ear.

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.